Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Solary, E' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 110 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ahmed, M; Dusanter-Fourt, I; Dugray, A; Dubrez, L; Novault, S; Bonnet, ML; Gisselbrecht, S; Varet, B; Solary, E; Vainchenker, W; Turhan, AG
      BCR-ABL fails to inhibit apoptosis in U937 myelomonocytic cells expressinga carboxyl-terminal truncated Stat5

      LEUKEMIA & LYMPHOMA
    2. Gurbuxani, S; Bruey, JM; Fromentin, A; Larmonier, N; Parcellier, A; Jaattela, M; Martin, F; Solary, E; Garrido, C
      Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells

      ONCOGENE
    3. Droin, N; Rebe, C; Bichat, F; Hammann, A; Bertrand, R; Solary, E
      Modulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization

      ONCOGENE
    4. Shao, RG; Cao, CX; Nieves-Neira, W; Dimanche-Boitrel, MT; Solary, E; Pommier, Y
      Activation of the Fas pathway independently of Fas ligand during apoptosisinduced by camptothecin in p53 mutant human colon carcinoma cells

      ONCOGENE
    5. Plenchette, S; Moutet, M; Benguella, M; N'Gondara, JP; Guigner, F; Coffe, C; Corcos, L; Bettaieb, A; Solary, E
      Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion

      LEUKEMIA
    6. Brey, J; Solary, E; Eymin, B
      p53 is involved in E2F-1 induced apoptose

      M S-MEDECINE SCIENCES
    7. Bonnotte, B; Larmonier, N; Favre, N; Fromentin, A; Moutet, M; Martin, M; Gurbuxani, S; Solary, E; Chauffert, B; Martin, F
      Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system

      JOURNAL OF IMMUNOLOGY
    8. Zermati, Y; Garrido, C; Amsellem, S; Fishelson, S; Bouscary, D; Valensi, F; Varet, B; Solary, E; Hermine, O
      Caspase activation is required for terminal erythroid differentiation

      JOURNAL OF EXPERIMENTAL MEDICINE
    9. Dubrez, L; Coll, JL; Hurbin, A; Solary, E; Favrot, MC
      Caffeine sensitizes human H358 cell line to p53-mediated apoptosis by inducing mitochondrial translocation and conformational change of BAX protein

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Lacour, S; Hammann, A; Wotawa, A; Corcos, L; Solary, E; Dimanche-Boitrel, MT
      Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis

      CANCER RESEARCH
    11. Droin, N; Bichat, F; Rebe, C; Wotawa, A; Sordet, O; Hammann, A; Bertrand, R; Solary, E
      Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells

      BLOOD
    12. Sordet, O; Rebe, C; Leroy, I; Bruey, JM; Garrido, C; Miguet, C; Lizard, G; Plenchette, S; Corcos, L; Solary, E
      Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis

      BLOOD
    13. Bruey, JM; Ducasse, C; Bonniaud, P; Ravagnan, L; Susin, SA; Diaz-Latoud, C; Gurbuxani, S; Arrigo, AP; Kroemer, G; Solary, E; Garrido, C
      Hsp27 negatively regulates cell death by interacting with cytochrome c

      NATURE CELL BIOLOGY
    14. Bruey, JM; Paul, C; Fromentin, A; Hilpert, S; Arrigo, AP; Solary, E; Garrido, C
      Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo

      ONCOGENE
    15. Solary, E; Mannone, L; Moreau, D; Caillot, D; Casasnovas, RO; Guy, H; Grandjean, M; Wolf, JE; Andre, F; Fenaux, P; Canal, P; Chauffert, B; Wotawa, A; Bayssas, M; Gennes, P
      Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes

      LEUKEMIA
    16. Solary, E; Droin, N; Bettaieb, A; Corcos, L; Dimanche-Boitrel, MT; Garrido, C
      Positive and negative regulation of apoptotic pathways by cytotoxic agentsin hematological malignancies

      LEUKEMIA
    17. Solary, E; Boitrel, MTD; Bettaieb, A
      Preassembled TNF receptors

      M S-MEDECINE SCIENCES
    18. Harousseau, JL; Witz, B; Lioure, B; Hunault-Berger, M; Desablens, B; Delain, M; Guilhot, F; Le Prise, PY; Abgrall, JF; Deconinck, E; Guyotat, D; Vilque, JP; Casassus, P; Tournilhac, O; Audhuy, B; Solary, E
      Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: Results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques

      JOURNAL OF CLINICAL ONCOLOGY
    19. Dimanche-Boitrel, MT; Micheau, O; France, D; Hammann, A; Duchamp, O; Genne, P; Solary, E
      P27(KiP1) overexpression inhibits the growth and doxorubicin sensitivity of HT29 human colon cancer cells in vivo

      ANTICANCER RESEARCH
    20. Eleouet, JF; Slee, EA; Saurini, F; Castagne, N; Poncet, D; Garrido, C; Solary, E; Martin, SJ
      The viral nucleocapsid protein of transmissible gastroenteritis coronavirus (TGEV) is cleaved by caspase-6 and-7 during TGEV-induced apoptosis

      JOURNAL OF VIROLOGY
    21. Bonnotte, B; Favre, N; Moutet, M; Fromentin, A; Solary, E; Martin, M; Martin, F
      Role of tumor cell apoptosis in tumor antigen migration to the draining lymph nodes

      JOURNAL OF IMMUNOLOGY
    22. Favre-Felix, N; Fromentin, A; Hammann, A; Solary, E; Martin, F; Bonnotte, B
      Cutting edge: The tumor counterattack hypothesis revisited: Colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway

      JOURNAL OF IMMUNOLOGY
    23. Favre-Felix, N; Martin, M; Maraskovsky, E; Fromentin, A; Moutet, M; Solary, E; Martin, F; Bonnotte, B
      Flt3 ligand lessens the growth of tumors obtained after colon cancer cell injection in rats but does not restore tumor-suppressed dendritic cell function

      INTERNATIONAL JOURNAL OF CANCER
    24. Droin, N; Beauchemin, M; Solary, E; Bertrand, R
      Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade

      CANCER RESEARCH
    25. de Botton, S; Chevret, S; Sanz, M; Dombret, H; Thomas, X; Guerci, A; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Geiser, K; Hess, U; Maloisel, F; Castaigne, S; Preudhomme, C; Chomienne, C; Degos, L; Fenaux, P
      Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial

      BRITISH JOURNAL OF HAEMATOLOGY
    26. Maillefert, JF; Duchamp, O; Solary, E; Genne, P; Tavernier, C
      Effects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells

      ANNALS OF THE RHEUMATIC DISEASES
    27. Sordet, O; Bettaieb, A; Bruey, JM; Eymin, B; Droin, N; Ivarsson, M; Garrido, C; Solary, E
      Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells

      CELL DEATH AND DIFFERENTIATION
    28. Arnal, M; Solary, E; Brunet-Lecomte, P; Lizard-Nacol, S
      Expression of the gadd153 gene in normal and tumor breast tissues by a sensitive RT-PCR method

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    29. Eymin, B; Haugg, M; Droin, N; Sordet, O; Dimanche-Boitrel, MT; Solary, E
      p27(Kip1) induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells

      ONCOGENE
    30. Eymin, B; Sordet, O; Droin, N; Munsch, B; Haugg, M; Van de Craen, M; Vandenabeele, P; Solary, E
      Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27(Kip1) mediates its anti-apoptotic activity

      ONCOGENE
    31. Garrido, C; Bruey, JM; Fromentin, A; Hammann, A; Arrigo, AP; Solary, E
      HSP27 inhibits cytochrome c-dependent activation of procaspase-9

      FASEB JOURNAL
    32. Wattel, E; Solary, E; Leleu, X; Dreyfus, F; Brion, A; Jouet, JP; Hoang-Ngoc, L; Maloisel, F; Guerci, A; Rochant, H; Gratecos, N; Casassus, P; Janvier, M; Brice, P; Lepelley, P; Fenaux, P
      A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

      LEUKEMIA
    33. Dimanche-Boitrel, MT; Micheau, O; Solary, E
      Anticancer drugs induce apoptosis via direct activation of Fas recceptor independently of its ligand FasL.

      M S-MEDECINE SCIENCES
    34. Micheau, O; Solary, E; Hammann, A; Dimanche-Boitrel, MT
      Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs

      JOURNAL OF BIOLOGICAL CHEMISTRY
    35. Favre, N; Bonnotte, B; Droin, N; Fromentin, A; Solary, E; Martin, F
      Fas(CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejection

      INTERNATIONAL JOURNAL OF CANCER
    36. Bettaieb, A; Sordet, O; Belon, JP; Solary, E
      Apoptosis and chemotherapy

      BULLETIN DU CANCER
    37. Rieux-Laucat, F; Blachere, S; Danielan, S; De Villartay, JP; Oleastro, M; Solary, E; Bader-Meunier, B; Arkwright, P; Pondare, C; Bernaudin, F; Chapel, H; Nielsen, S; Berrah, M; Fischer, A; Le Deist, F
      Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations

      BLOOD
    38. Fenaux, P; Chastang, C; Chevret, S; Sanz, M; Dombret, H; Archimbaud, E; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Maloisel, F; Castaigne, S; Preudhomme, C; Degos, L
      A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia

      BLOOD
    39. Micheau, O; Hammann, A; Solary, E; Dimanche-Boitrel, MT
      STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    40. BONNOTTE B; FAVRE N; REVENEAU S; MICHEAU O; DROIN N; GARRIDO C; FONTANA A; CHAUFFERT B; SOLARY E; MARTIN F
      CANCER CELL SENSITIZATION TO FAS-MEDIATED APOPTOSIS BY SODIUM-BUTYRATE

      Cell death and differentiation
    41. TURHAN AG; SOLARY E; VAINCHENKER W; DUSANTERFOURT I
      MOLECULAR PATHOPHYSIOLOGY OF CHRONIC MYELOGENOUS LEUKEMIA

      HEMATOLOGY AND CELL THERAPY
    42. LENORMAND B; BENE MC; LESESVE JF; BASTARD C; TILLY H; LEFRANC MP; FAURE GC; GARAND R; FALKENRODT A; KANDEL G; SOLARY E; MAYNADIE M; CALLAT MP; THOURET F; MONCONDUIT M; VANNIER JP
      PREB1 (CD10(-)) ACUTE LYMPHOBLASTIC-LEUKEMIA - IMMUNOPHENOTYPIC AND GENOMIC CHARACTERISTICS, CLINICAL-FEATURES AND OUTCOME IN 38 ADULTS AND26 CHILDREN

      Leukemia & lymphoma
    43. DROIN N; DUBREZ L; EYMIN B; RENVOIZE C; BREARD J; DIMANCHEBOITREL MT; SOLARY E
      UP-REGULATION OF CASP GENES IN HUMAN TUMOR-CELLS UNDERGOING ETOPOSIDE-INDUCED APOPTOSIS

      Oncogene
    44. Chauffert, B; Dimanche-Boitrel, MT; Garrido, C; Ivarsson, M; Martin, M; Martin, F; Solary, E
      New insights into the kinetic resistance to anticancer agents

      CYTOTECHNOLOGY
    45. Lizard, G; Gueldry, S; Sordet, O; Monier, S; Athias, A; Miguet, C; Bessede, G; Lemaire, S; Solary, E; Gambert, P
      Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production

      FASEB JOURNAL
    46. CASASNOVAS RO; CAMPOS L; MUGNERET F; CHARRIN C; BENE MC; GARAND R; FAVRE M; SARTIAUX C; CHAUMAREL I; BERNIER M; FAURE G; SOLARY E
      IMMUNOPHENOTYPIC PATTERNS AND CYTOGENETIC ANOMALIES IN ACUTE NONLYMPHOBLASTIC LEUKEMIA SUBTYPES - A PROSPECTIVE-STUDY OF 432 PATIENTS

      Leukemia
    47. SOLARY E; EYMIN B; DROIN N; HAUGG M
      PROTEASES, PROTEOLYSIS, AND APOPTOSIS

      Cell biology and toxicology
    48. FOUILLARD L; DECONINCK E; TIBERGHIEN P; DESCHASEAUX ML; SOLARY E; MUGNERET F; BRION A; HERVE P; CAHN JY
      PROLONGED REMISSION AND AUTOLOGOUS RECOVERY IN 2 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA AFTER GRAFT FAILURE OF ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    49. BONNOTTE B; FAVRE N; MOUTET M; FROMENTIN A; SOLARY E; MARTIN M; MARTIN F
      BCL-2-MEDIATED INHIBITION OF APOPTOSIS PREVENTS IMMUNOGENICITY AND RESTORES TUMORIGENICITY OF SPONTANEOUSLY REGRESSIVE TUMORS

      The Journal of immunology (1950)
    50. DIMANCHEBOITREL MT; MICHEAU O; HAMMANN A; HAUGG M; EYMIN B; CHAUFFERT B; SOLARY E
      CONTRIBUTION OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27(KIP1) TO THE CONFLUENCE-DEQENDENT RESISTANCE OF HT29 HUMAN COLON-CARCINOMA CELLS

      International journal of cancer
    51. Garrido, C; Fromentin, A; Bonnotte, B; Favre, N; Moutet, M; Arrigo, AP; Mehlen, P; Solary, E
      Heat shock protein 27 enhances the tumorigenicity of immunogenic rat coloncarcinoma cell clones

      CANCER RESEARCH
    52. SOLARY E; MICHEAU O; DIMANCHEBOITREL MT; MARTIN F
      ROLE OF THE FAS FAS-L SYSTEM IN THE IMMUNE-RESPONSE TO TUMORS AND THERESISTANCE TO CYTOTOXIC DRUGS/

      Bulletin du cancer
    53. WATTEL E; SOLARY E; HECQUET B; CAILLOT D; IFRAH N; BRION A; MAHE B; MILPIED N; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; BUZYN A; HOANGNGOC L; STOPPA AM; GRATECOS N; SADOUN A; STAMATOULAS A; TILLY H; BRICE P; MALOISEL F; LIOURE B; DESABLENS B; PIGNON B; ABGRALL JP; LEPORRIER M; DUPRIEZ B; GUYOTAT D; LEPELLEY P; FENAUX P
      QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY

      British Journal of Haematology
    54. HAROUSSEAU JL; WITZ F; LIOURE B; LEPRISE PY; SOLARY E; ABGRALL JF; CASSASUS P; AUDHUY B; TRAVADE P; CAHN JY
      G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) IN ACUTE MYELOID-LEUKEMIA (AML)

      British Journal of Haematology
    55. LARGHERO J; ROUSSELOT P; MICLEA JM; SOLARY E; CHOMIENNE C
      DIFFERENTIAL-EFFECTS OF ALL-TRANS-RETINOIC ACID ON ACUTE PROMYELOCYTIC LEUKEMIA-CELLS RELATED TO THE EXPRESSION OF CD34 ANTIGEN

      British Journal of Haematology
    56. WATTEL E; SOLARY E; HECQUET B; CAILLOT D; IFRAH N; BRION A; MILPIED N; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; VEIL A; HOANGNGOC L; STOPPA AM; GRATECOS N; SADOUN A; TILLY H; BRICE B; GUYOTAT D; LEPELLEY P; FENAUX P
      QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY

      British Journal of Haematology
    57. WATTEL E; LELEU X; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET JP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGUEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
      AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)

      British Journal of Haematology
    58. DUBREZ L; EYMIN B; SORDET O; DROIN N; TURHAN AG; SOLARY E
      BCR-ABL DELAYS APOPTOSIS UPSTREAM OF PROCASPASE-3 ACTIVATION

      Blood
    59. MAYNADIE M; CAMPOS L; MOSKOVTCHENKO P; SABIDO O; AHO S; LENORMAND B; CARLI PM; GUYOTAT D; BENE MC; FAURE G; CAPIOD JC; GARDAIS J; FEUILLARD J; RAPHAEL M; LACOMBE R; LECALVEZ G; LEGLISE MC; DENEYS V; MASSON AM; BERNIER M; MALET AM; SALAUN C; BOURIN P; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; CHRETIEN P; SOLARY E; CASASNOVAS RO; MAYNADIE M; MOSKOVTCHENKO P; FAVRE M; BENSA JC; JACOB MC; WALLEF G; SARIAUX C; TRIMOREAU F; PRALORAN V; CAMPOS L; SABIDO O; VASSELON C; BRUNET C; PONCELET P; GUITARD AM; TAIB J; LAVABREBERTRAND T; JUNG G; KANDEL G; GARAND R; PHILIP P; SUDAKA I; MONPOUX F; VANHAEKE D; PERROT JY; MARIE JP; VALENSI F; VERGE V; HOMBERG JC; SCHAISON G; BOUMSELL L; DOUAY L; SAMSON T; BRIZARD A; DALIPHARD S; DRENOU B; LEES O; LENORMAND B; POILANE B; FALKENRODT A; ALBERT A; KUHLEIN E; ESTIENNE MH; BREMOND JL; DEGENNE M; LEBARON F; REUMAUX G; DUTHILLEUL P; BENE MC; FAURE G; BORDIGONI P; WITZ F; KOLLOPSARDA MN; BAYLE C; ANTONINI J; BOUCHEIX C; CHARPENTIER A
      HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS

      Leukemia & lymphoma
    60. CAILLOT D; CASASNOVAS O; BERNARD A; COUAILLIER JF; DURAND C; CUISENIER B; SOLARY E; PIARD F; PETRELLA T; BONNIN A; COUILLAULT G; DUMAS M; GUY H
      IMPROVED MANAGEMENT OF INVASIVE PULMONARY ASPERGILLOSIS IN NEUTROPENIC PATIENTS USING EARLY THORACIC COMPUTED TOMOGRAPHIC SCAN AND SURGERY

      Journal of clinical oncology
    61. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; IFRAH N; ABGRALL JP; GUYOTAT D; DUPRIEZ B; PENY AM; BRICE P; PIGNON B; LEPORRIER M; LEPELLEY P; FENAUX P
      INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS)

      Experimental hematology
    62. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET JP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
      AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)

      Experimental hematology
    63. REBIBOU JM; CAILLOT D; CASASNOVAS RO; TANTER Y; MAILLARD N; SOLARY E; RIFLE G; GUY H
      PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN A MULTIPLE-MYELOMA PATIENT WITH END-STAGE RENAL-FAILURE

      Bone marrow transplantation
    64. EYMIN B; DUBREZ L; ALLOUCHE M; SOLARY E
      INCREASED GADD153 MESSENGER-RNA LEVEL IS ASSOCIATED WITH APOPTOSIS INHUMAN LEUKEMIC-CELLS TREATED WITH ETOPOSIDE

      Cancer research
    65. LARGHERO J; ROUSSELOT P; MICLEA JM; SOLARY E; CHOMIENNE C
      DIFFERENTIAL EFFECT OF ALL-TRANS-RETINOIC ACID ON ACUTE PROMYELOCYTICLEUKEMIA-CELLS RELATED TO THE EXPRESSION OF CD34 ANTIGEN

      Blood
    66. LIOURE B; WITZ F; DECONNINCK E; DELAIN M; SOLARY E; BERTHOU C; AUDHUY B; FRANCOIS S; GUYOTAT D; SADDOUN A; PIGNON B; HAROUSSEAU JL; OBERLING F
      AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) REPRESENTS THE BEST CONSOLIDATION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR) - A RETROSPECTIVE STUDY OF THE GOELAMS GROUP

      Blood
    67. HAROUSSEAU JL; WITZ F; DESABLENS B; LEPRISE PY; FRANCOIS S; DELAIN M; ABGRALL JF; SOLARY E
      G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML)

      Blood
    68. MICHEAU O; SOLARY E; HAMMANN A; MARTIN F; DIMANCHEBOITREL MT
      SENSITIZATION OF CANCER-CELLS TREATED WITH CYTOTOXIC DRUGS TO FAS-MEDIATED CYTOTOXICITY

      Journal of the National Cancer Institute
    69. SOLARY E; DUBREZ L; EYMIN B
      THE ROLE OF APOPTOSIS IN THE PATHOGENESIS AND TREATMENT OF DISEASES

      The European respiratory journal
    70. CAHN JY; HAROUSSEAU JL; PIGNON B; WITZ F; DELAIN M; LIOURE B; LAMY T; SOLARY E; DESABLENS B; BRIERE J; CASSASUS P; AUDHUY B; POLIN V; HURTELOUP P; TELLIER Z
      AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT SUPERIOR TO INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) FOR POSTREMISSION THERAPY IN ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - FINAL ANALYSIS OF THE GOELAMS STUDY

      Experimental hematology
    71. DUBREZ L; SAVOY I; HAMMAN A; SOLARY E
      PIVOTAL ROLE OF A DEVD-SENSITIVE STEP IN ETOPOSIDE-INDUCED AND FAS-MEDIATED APOPTOTIC PATHWAYS

      EMBO journal
    72. SOLARY E; DUBREZ L; EYMIN B; BERTRAND R; POMMIER Y
      APOPTOSIS INDUCTION IN HUMAN LEUKEMIC-CEL LS BY TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS

      Bulletin du cancer
    73. SOLARY E; WITZ B; CAILLOT D; MOREAU P; DESABLENS B; CAHN JY; SADOUN A; PIGNON B; BERTHOU C; MALOISEL F; GUYOTAT D; CASASSUS P; IFRAH N; LAMY Y; AUDHUY B; COLOMBAT P; HAROUSSEAU JL
      COMBINATION OF QUININE AS A POTENTIAL REVERSING AGENT WITH MITOXANTRONE AND CYTARABINE FOR THE TREATMENT OF ACUTE LEUKEMIAS - A RANDOMIZED MULTICENTER STUDY

      Blood
    74. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET IP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
      PROSPECTIVE-STUDY OF AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)

      Blood
    75. AHMED A; DUPREZ I; NOVAULT S; SOLARY E; VAINCHENKER W; VARET V; TURHAN AG
      BCR-ABL P210 FAILS TO INHIBIT APOPTOSIS IN U937 CELLS

      Blood
    76. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; HOANGNGOC L; MALOSIEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; IFRAH N; ABGRALL IP; GUYOTAT D; DUPRIEZ B; PENY AM; BRICE P; PIGNON B; LEPORRIER M; LEPELLEY P; FENAUX P
      QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP)

      Blood
    77. CASASNOVAS RO; CAMPOS L; MUGNERET F; SARTIAUX C; CHARRIN C; BERNIER M; FAVRE M; GARAND R; CHAUMAREL I; BENE MC; FAURE G; SOLARY E
      IMMUNOPHENOTYPIC FEATURES OF CYTOGENETICALLY DEFINED ACUTE MYELOBLASTIC-LEUKEMIA (AML) SUBTYPES - A PROSPECTIVE-STUDY OF 432 PATIENTS

      Blood
    78. MASSING JL; CAILLOT D; MOUHAT T; SCHLESSER P; SOLARY E
      EARLY DIAGNOSIS OF ANTHRACYCLINE CARDIOTO XICITY - VALUE OF RADIOISOTOPIC METHODS

      Archives des maladies du coeur et des vaisseaux
    79. VANHAEKE DR; BENE MC; GARAND R; FAURE GC; GARDAIS J; LEGLISE MC; LECALVEZ G; BERNIER M; MASSY M; GRIVEAU AM; BROUTARD P; LEBRUN C; BONHOMME J; CHASSAGNE B; DEMEOCQ F; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; CHRETIEN P; SOLARY E; CASASNOVAS RO; MAYNADIE M; BENSA JC; FAVRE M; JACOB MC; SARTIAUX C; HUART JL; DROUET M; PRALORAN V; TRIMOREAU F; CAMPOS L; LARESE A; PONCELET P; BESSONFAURE I; BRUNET C; LAVABREBERTRAND T; TAIB J; KANDEL G; JUNG G; HARROUSSEAU JL; PHILIP P; MONPOUX F; BAUDOUIN F; SUDAKA I; CALDANI C; VANHAEKE D; BERNARD A; VALENSI F; BOURIN P; ARBORIO M; SCHAISON G; BOUMSELL L; ADAM M; DOUAI L; BRIZARD A; DALIPHARD S; GENETET N; FAUCHET R; DRENOU B; LEES O; LENORMAND B; VANNIER JP; SABIDO O; GUYOTAT D; VASSELON C; FALKENRODT A; ALBERT A; BREMOND JL; GEORGET MT; KUHLEIN E; LEBARON F; DUTHILLEUL P; REUMAUX F; FAURE G; KOLOPPSARDA MN; BORDIGONI P; WITZ F; BAYLE C; ANTONINI J; CHARPENTIER A
      EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia & lymphoma
    80. DUBREZ L; GOLDWASSER F; GENNE P; POMMIER Y; SOLARY E
      THE ROLE OF CELL-CYCLE REGULATION AND APOPTOSIS TRIGGERING IN DETERMINING THE SENSITIVITY OF LEUKEMIC-CELLS TO TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS

      Leukemia
    81. MUGNERET F; SIDANER I; FAVRE B; MANONE L; MAYNADIE M; CAILLOT D; SOLARY E
      DER(16)T(1-16)(Q10-P10) IN MULTIPLE-MYELOMA - A NEW NONRANDOM ABNORMALITY THAT IS FREQUENTLY ASSOCIATED WITH BURKITTS-TYPE TRANSLOCATIONS

      Leukemia
    82. BERTRAND R; KOHN KW; SOLARY E; POMMIER Y
      DETECTION OF APOPTOSIS-ASSOCIATED DNA FRAGMENTATION USING A RAPID ANDQUANTITATIVE FILTER ELUTION ASSAY

      Drug development research
    83. GENNE P; DUCHAMP O; SOLARY E; MAGNETTE J; BELON JP; CHAUFFERT B
      CINCHONINE PER-OS - EFFICIENT CIRCUMVENTION OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE

      Anti-cancer drug design
    84. MABOUNDOU CW; MAGNETTE J; PAINTAUD G; DUPOND JL; FEST T; NAJMAN A; SOLARY E; XICLUNA A; SIRITO A; CAHN JY
      PHARMACOKINETICS OF A MORE RELIABLE CHLORAMINOPHENE(R) FORMULATION

      Nouvelle revue francaise d'hematologie
    85. EYMIN B; SOLARY E; CHEVILLARD S; DUBREZ L; GOLDWASSER F; DUCHAMP O; GENNE P; LETEURTRE F; POMMIER Y
      CELLULAR PHARMACOLOGY OF AZATOXINS (TOPOISOMERASE-II AND TUBULIN INHIBITORS) IN P-GLYCOPROTEIN-POSITIVE AND P-GLYCOPROTEIN-NEGATIVE CELL-LINES

      International journal of cancer
    86. GUIGUET M; DUVILLARD L; SOLARY E
      SERUM IL-6 CONCENTRATIONS IN LYMPHOMA - REPLY

      British Journal of Haematology
    87. MUGNERET F; DASTUGUE N; FAVRE B; SIDANER I; SALLES B; HUGUETRIGAL F; SOLARY E
      DER(16)T(1-16)(Q11-Q11) IN MYELODYSPLASTIC SYNDROMES - A NEW NONRANDOM ABNORMALITY CHARACTERIZED BY CYTOGENIC AND FLUORESCENCE IN-SITU HYBRIDIZATION STUDIES

      British Journal of Haematology
    88. DUVILLARD L; GUIGUET M; CASASNOVAS RO; CAILLOT D; MONNIERZELLER V; BERNARD A; GUY H; SOLARY E
      DIAGNOSTIC-VALUE OF SERUM IL-6 LEVEL IN MONOCLONAL GAMMOPATHIES

      British Journal of Haematology
    89. DUBREZ L; EYMIN B; SOLARY E
      INVOLVEMENT OF AN ICE-INDEPENDENT PROTEOLYTIC PATHWAY IN APOPTOTIC DNA FRAGMENTATION INDUCED BY VP-16 IN U937 CELLS

      Blood
    90. EYMIN B; DUBREZ L; SOLARY E
      RELATIONSHIP BETWEEN GADD153 GENE-EXPRESSION AND DNA FRAGMENTATION INLEUKEMIC-CELLS SENSITIVE TO APOPTOSIS INDUCTION BY VP-16

      Blood
    91. SOLARY E; WITZ B; CAILLOT D; MOREAU P; DESABLENS B; CAHN JY; MALOISEL F; SADOUN A; PIGNON B; GUYOTAT D; CASASSUS P; IFRAH N; AUDHUY B; BERTHOU C; DELAIN M; LAMY T; HAROUSSEAU JL
      PROSPECTIVE MULTICENTRIC RANDOMIZED STUDY OF QUININE AS A POTENTIAL MDR-REVERSING AGENT FOR THE TREATMENT OF ACUTE LEUKEMIAS

      Blood
    92. WATTEL P; SOLARY E; CAILLOT D; IFRAH N; BRIAN A; MAHE B; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; VEIL A; STOPPA AM; GRATECOS N; SADOUN A; TILLY H; BRICE P; LIOURE B; DESABLENS E; PIGNON B; ABGRALL IP; LEPORRIER M; DUPRIEZ B; GUYOTAT D; MERLAT A; FENAUX P
      INTENSIVE CHEMOTHERAPY (CT) WITH OR WITHOUT QUININE FOLLOWED BY AUTOLOGOUS BMT IN MYELODYSPLASTIC SYNDROMES (MDS) AND SECONDARY LEUKEMIAS (SL) - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL

      Blood
    93. CAILLOT D; DURAND C; CASASNOVAS O; COUAILLIER JF; BERNARD A; BUISSON M; SOLARY E; BRACHET A; CUISENIER B; BONNIN A; DEBUCHE V; DEMONTAIGNAC A; MAGNIN G; ARNOULD L; PETRELLA T; GUY H
      INVASIVE PULMONARY ASPERGILLOSIS IN NEUTR OPENIC PATIENTS - A REPORT OF 36 CASES - ROLE OF THORACIC CT-SCAN AND ITRACONAZOL

      Annales de medecine interne
    94. SOLARY E; BERTRAND R; POMMIER Y
      APOPTOSIS INDUCED BY DNA TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS IN HUMAN LEUKEMIC HL-60 CELLS

      Leukemia & lymphoma
    95. GARAND R; BENE MC; GARDAIS J; DUBOSCMARCHENAY N; LACOMBE F; LEGLISE MC; LECALVEZ G; BERNIER M; MASSY M; GRIVEAU AM; BROUTARD P; LEBRUN C; BONHOMME J; CHASSAGNE B; DEMEOCQ F; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; SOLARY E; CASASNOVAS RO; MAYNADIE M; BENSA JC; FAVRE M; JACOB MC; SARTIAUX C; HUART JL; DROUET M; PRALORAN V; TRIMOREAU F; CAMPOS L; LARESE A; PONCELET P; BESSONFAURE I; BRUNET C; LAVABREBERTRAND TL; TAIB J; KANDEL G; JUNG G; HARROUSSEAU JL; PHILIP P; MONPOUX F; BAUDOUIN F; SUDAKA I; CALDANI C; POMIER G; BERNARD A; REGUER M; SCHILL H; BOURIN P; ARBORIO M; SCHAISON G; BOUMSELL L; ADAM M; DOUAI L; VANHAECKE D; BRIZARD A; ROUALET JP; TABARY T; CHAUMAREL I; GENETET N; FAUCHET R; DRENOU B; LEES O; LENORMAND B; VANNIER JP; LEPETIT JC; ACQUART S; SABIDO O; GUYOTAT D; VASSELON C; FALKENRODT A; ALBERT A; BREMOND JL; GEORGET MT; ROUBINET F; KUHLEIN E; LEBARON F; DUTHILLEUL P; REUMAUX F; FAURE G; KOLOPPSARDA MN; BORDIGONI P; WITZ F; BAYLE C; ANTONINI J; CHARPENTIER A
      A NEW APPROACH OF ACUTE LYMPHOBLASTIC-LEUKEMIA IMMUNOPHENOTYPIC CLASSIFICATION - 1984-1994 THE GEIL EXPERIENCE

      Leukemia & lymphoma
    96. CASASNOVAS RO; SOLARY E; CAMPOS L; MAYNADIE M; FAVRE M; BREMEND JL; GARAND R; BENE MC; FAURE G
      PROGNOSTIC RELEVANCE OF SURFACE-MARKERS IN ADULT DE-NOVO ACUTE MYELOBLASTIC LEUKEMIAS - A PROSPECTIVE-STUDY OF THE GROUPE DETUDE IMMUNOLOGIQUE DES LEUCEMIES (GEIL)

      Leukemia & lymphoma
    97. SOLARY E; BERTRAND R; POMMIER Y
      APOPTOSIS OF HUMAN LEUKEMIC HL-60 CELLS INDUCED TO DIFFERENTIATE BY PHORBOL ESTER TREATMENT

      Leukemia
    98. GENNE P; DUCHAMP O; SOLARY E; PINARD D; BELON JP; DIMANCHEBOITREL MT; CHAUFFERT B
      COMPARATIVE EFFECTS OF QUININE AND CINCHONINE IN REVERSING MULTIDRUG-RESISTANCE ON HUMAN LEUKEMIC-CELL LINE K562 ADM/

      Leukemia
    99. POMMIER Y; LETEURTRE F; FESEN MR; FUJIMORI A; BERTRAND R; SOLARY E; KOHLHAGEN G; KOHN KW
      CELLULAR DETERMINANTS OF SENSITIVITY AND RESISTANCE TO DNA TOPOISOMERASE INHIBITORS

      Cancer investigation
    100. SOLARY E; GENNE P; WITZ B; MILPIED N; CAHN JY; MALOISEL F; QUIQUANDON I; SADOUN A; IFRAH N; CASASSUS P; BERTHOUX P; AUDHUY B; PIGNON B; LAMY T; GUYOTAT D; COLOMBAT P; STOPPA AM; KUENTZ M; GUY H; HAROUSSEAU JL
      CLINICAL-TRIALS OF THERAPEUTIC MDR REVERS ION IN ACUTE LEUKEMIAS

      Pathologie et biologie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 21:34:28